![]() 001630 6 months ago | Other | ₩1,400 Per Share |
![]() 001630 27 Dec 2023 | Other | ₩1,400 Per Share |
![]() 001630 28 Dec 2022 | Other | ₩1,400 Per Share |
![]() 001630 29 Dec 2021 | Other | ₩1,400 Per Share |
![]() 001630 29 Dec 2020 | Other | ₩1,400 Per Share |
12 Aug 2025 (In 2 weeks) Date | | - Cons. EPS | - EPS |
16 May 2025 Date | | - Cons. EPS | - EPS |
15 May 2025 Date | | - Cons. EPS | 1.25K EPS |
14 May 2025 Date | | - Cons. EPS | - EPS |
11 Feb 2025 Date | | - Cons. EPS | - EPS |
![]() 001630 6 months ago | Other | ₩1,400 Per Share |
![]() 001630 27 Dec 2023 | Other | ₩1,400 Per Share |
![]() 001630 28 Dec 2022 | Other | ₩1,400 Per Share |
![]() 001630 29 Dec 2021 | Other | ₩1,400 Per Share |
![]() 001630 29 Dec 2020 | Other | ₩1,400 Per Share |
12 Aug 2025 (In 2 weeks) Date | | - Cons. EPS | - EPS |
16 May 2025 Date | | - Cons. EPS | - EPS |
15 May 2025 Date | | - Cons. EPS | 1.25K EPS |
14 May 2025 Date | | - Cons. EPS | - EPS |
11 Feb 2025 Date | | - Cons. EPS | - EPS |
Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Tae Young Kim CEO | KRX SM Exchange | KR7001630003 ISIN |
KR Country | 37 Employees | - Last Dividend | 6 Dec 2013 Last Split | - IPO Date |
Chong Kun Dang Holdings Corp. is a well-established entity in the pharmaceutical industry, focusing on the manufacture and distribution of pharmaceutical products. With its inception in 1941, it has grown to serve not only the domestic market in South Korea but also an international clientele. The headquarters of Chong Kun Dang Holdings Corp. is located in Seoul, South Korea, indicating its central role in the country’s pharmaceutical landscape. Through decades of operation, the company has built a reputation for delivering quality pharmaceutical products, contributing to healthcare and medical treatments worldwide.
Chong Kun Dang Holdings Corp. offers a diverse portfolio of pharmaceutical products that cater to a wide range of medical needs. The company's products and services include: